FILTER

Refine your search with the following facets to narrow down your results.

6 Current news of Axxam

Axxam and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU

29-Jul-2011 - Axxam Spa and Polyphor Ltd announced a joint discovery research project for the generation of GLP-1R modulators. The partnership will receive funding from the EU as part of the Eurostars Program aimed at supporting innovation within the European Union.The two companies will undertake a three-year ...

type 2 diabetes

Polyphor Ltd and Axxam SpA Announce Ion Channel Collaboration

13-Apr-2010 - Polyphor Ltd and Axxam SpA announced a joint discovery agreement with a synergistic combination of their discovery platforms. Under the terms of the collaboration the two companies will work together to discover and develop innovative drug candidates for selected therapeutic areas such as pain, ...

drug development inflammation ion channels +2

CyBio and Axxam Develop a New System for High Throughput Screening

20-Mar-2009 - CyBio AG and Axxam SpA announce that they have developed, installed and validated a new screening station to be used by Axxam in running hit discovery campaigns with automated luminescence and fluorescence screening systems. The new workstation, which will run in parallel to another CyBio ...

density fluorescence heating +1

InterMed Discovery and Axxam Announce Joint Research Agreement for the Identification of Novel Natural Functional Ingredients

10-Mar-2009 - InterMed Discovery (IMD) and Axxam SpA announced that their joint research efforts have proved to be successful in providing a technology platform that offers, in addition to screening solutions, the discovery of natural bioactive compounds. These bioactive compounds are particularly valuable to ...

food Life Sciences research agreements +1

Genedata and Axxam announce high throughput screening data analysis collaboration

07-Jul-2008 - Genedata, a provider of in silico solutions for the pharmaceutical and life science industries, and Axxam, a biotechnology research organization offering early-stage discovery research services for the life science industry, have signed a multi-year contract for the implementation of the Genedata ...

biotechnology contract research drug development +1

CyBio and Axxam sign collaboration agreement for drug discovery using automated luminescence screening systems

09-Feb-2005 - CyBio AG and Axxam srl have signed a contract to cooperate in the development and marketing of new technologies for drug discovery using automated luminescence screening systems. With this agreement, CyBio combines its excellent detection and automation technology with Axxam's proprietary ...

automation technology liquid handling luminescence +1